Our colleague anton managed to communicate with a significant part of this number of guests potkovenko, who is joining us now, yes, anton, today you have just a colossal number of interviews, both short and more extended, which of the guests have you yet managed to talk to . Natalia georgi, yes, today is really real the marathon was, as they say, an interview with those guests who came and were invited to the inauguration ceremony of Vladimir Putin as president of the Russian Federation, this was a completely special feeling. Which you know is now preserved here in the malachite faye, the guests are already beginning to leave, our colleagues are beginning to leave, but nevertheless, the significance of the moment , without exaggerating the historical moment that just happened, it remains, the energy of great hopes, the energy of Great Expectations at its best sense of the word, she is here, and speaking of impressions, what the guests who listened to the speech, the inauguration speech
At present, Phase 3 clinical trials of EpiVacCorona and CoviVac are under way
MOSCOW, April 14. /TASS/. Volunteers diagnosed with cancer can take part in phase three clinical trials of two Russian anti-coronavirus vaccines, EpiVacCorona and CoviVac, to help assess their efficacy and safety for oncology patients, according to a document obtained by TASS.
Earlier, Tatyana Kusaiko, the deputy chair of the social policy committee of the Federation Council (Russian parliament’s upper chamber), sent a request to Health Minsiter Mikhail Murashko, asking him to provide information about studies into the vaccines’ safety for cancer patients.
Read also
The Health Ministry’s official response, obtained by TASS, reads: While studying vaccines based on traditional and relatively well-studied technologies (such as whole-virion inactivated refined vaccine or a vaccine based on synthetic peptide antigens of the coronavirus), volunteers with cancer can take part in clinical trials. At pres